Drug intelligence / Profile preview

MyD88 siRNA

Development stage
Preclinical
Lead developer
University of Texas MD Anderson Cancer Center
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous
01

Overview

MyD88 siRNA is a small interfering RNA designed to silence the expression of the Myeloid Differentiation Primary Response 88 (MyD88) gene. MyD88 is a critical adapter protein in the Toll-like receptor (TLR) and Interleukin-1 receptor (IL-1R) signaling pathways, which are essential for innate immunity and inflammatory responses. In the context of oncology, particularly melanoma, aberrant MyD88 signaling has been implicated in promoting chronic inflammation, oxidative stress, and tumor cell survival. Preclinical research has demonstrated that siRNA-mediated knockdown of MyD88 in melanoma cell lines leads to significant growth inhibition, induction of autophagy, and a reduction in inflammatory markers such as Cox-2 and reactive oxygen species. This approach is being explored as a potential therapeutic strategy for melanoma patients with high constitutive expression of the IL-1/MyD88 signaling axis.

Other names
MyD88 small interfering RNAMyD-88 small interfering RNAMyD 88 small interfering RNA
02

Targets

MYD88 (Myeloid differentiation primary response protein MyD88)

Beyond the preview

Go deeper on MyD88 siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MyD88 siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call